Related Experiment Video
Updated: Dec 9, 2025

Isolation, Culture, and Differentiation of Bone Marrow Stromal Cells and Osteoclast Progenitors from Mice
Published on: January 6, 2018
KLF14 inhibits osteogenic differentiation of human bone marrow mesenchymal stem cells by downregulating WNT3A
Junquan Weng1, Jiahua Wu2, Weixuan Chen1
1Department of Stomatology, Shenzhen People's Hospital, Second Clinical Medical College of Jinan University Guangdong, P. R. China.
Abstract:
KLF14 belongs to the Krüppel-like factor (KLF) family of transcription factors. The KLF family activate and/or repress transcription in a promoter- and cell-dependent manner by interacting with co-suppressors or co-activators. However, the function and mechanism of KLF14 in osteogenic differentiation of human bone marrow mesenchymal stem cells (hMSCs) is unknown. This study explores the impact and molecular mechanism of KLF14 in hMSC osteogenic differentiation in vitro. We found that KLF14 was highly expressed in hMSCs, and KLF14 expression gradually decreased after inducing osteogenic differentiation. Inhibiting KLF14 expression promoted osteogenic differentiation of hMSCs. We also found that KLF14 interacted with the WNT3A promoter. This interaction decreased expression of WNT3A and downstream osteogenesis-related target genes in the WNT signaling pathway, and resulted in cell cycle arrest. In conclusion, we describe a new mechanism for KLF14 in differentiation of hMSCs into osteoblasts and suggest a new target for clinical therapeutics related to human bone development.
Insights
Krüppel-like factor 14 (KLF14) inhibits osteogenic differentiation in human bone marrow mesenchymal stem cells (hMSCs). Reducing KLF14 promotes bone development by influencing WNT3A signaling, offering a potential therapeutic target.
Area of Science:
- Molecular Biology
- Stem Cell Biology
- Biochemistry
Background:
- Krüppel-like factor 14 (KLF14) is part of a transcription factor family regulating gene expression.
- The specific role of KLF14 in human bone marrow mesenchymal stem cell (hMSC) osteogenic differentiation remains unexplored.
Purpose of the Study:
- To investigate the function and molecular mechanism of KLF14 during hMSC osteogenic differentiation in vitro.
- To elucidate KLF14's impact on the WNT signaling pathway and cell cycle progression.
Main Methods:
- Quantitative analysis of KLF14 expression in hMSCs.
- Inhibition of KLF14 expression to assess effects on osteogenic differentiation.
- Analysis of KLF14 interaction with the WNT3A promoter.
- Assessment of WNT3A expression and downstream gene targets.
- Cell cycle analysis.
Main Results:
- KLF14 is highly expressed in hMSCs and its expression decreases during osteogenic differentiation.
- Inhibition of KLF14 enhances hMSC osteogenic differentiation.
- KLF14 directly interacts with the WNT3A promoter, suppressing WNT3A expression and downstream osteogenesis-related genes.
- KLF14-mediated WNT3A downregulation leads to cell cycle arrest.
Conclusions:
- KLF14 acts as a negative regulator of osteogenic differentiation in hMSCs.
- KLF14 influences osteogenesis by modulating the WNT3A signaling pathway and cell cycle.
- KLF14 presents a novel therapeutic target for bone development disorders.
Related Concept Videos
Non-Canonical Wnt Signaling Pathways
Canonical Wnt Signaling Pathway
Mesenchymal Stem Cells

